Altamira Therapeutics Ltd. — POS AM Filings
12 POS AM filings on record
This page lists all POS AM filings submitted to the SEC by Altamira Therapeutics Ltd. (CYTOF), sorted by most recent first. Each row links to the full filing on EdgarLookup. Altamira Therapeutics Ltd. has filed 12 POS AM documents with the SEC since 2014. To view all SEC filings by Altamira Therapeutics Ltd., see the full filings list.
All
15-12G
15F-12B
20-F
20-F/A
25-NSE
424B3
424B4
424B5
6-K
6-K/A
8-A12B
8-A12B/A
8-K12G3
CERT
CERTNAS
CORRESP
CT ORDER
D
DRS
DRS/A
DRSLTR
EFFECT
F-1
F-1/A
F-1MEF
F-3
F-4
F-4/A
FWP
NT 20-F
POS AM
POS EX
RW
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13D/A
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-24-059862 | Jul 8, 2024 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-22-019866 | Apr 14, 2022 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-21-060083 | Nov 16, 2021 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 4 TO FORM F-1 | 0001213900-21-030525 | Jun 2, 2021 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 3 TO FORM F-1 | 0001213900-21-030402 | Jun 2, 2021 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 2 TO F-1 | 0001213900-20-013380 | May 26, 2020 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-20-013378 | May 26, 2020 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-19-006154 | Apr 11, 2019 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-19-006153 | Apr 11, 2019 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-1 | 0001213900-19-004566 | Mar 20, 2019 | — |
| POS AM | POST-EFFECTIVE AMENDMENT NO. 1 TO FORM F-3 | 0001213900-19-004564 | Mar 20, 2019 | — |
| POS AM | POS AM | 0001193125-14-303207 | Aug 8, 2014 | — |